ARIEL in leukemia [68], HPSE in different cancer types [69], and P2RY2 in bladder cancer [70] are other examples of eRNAs targeted by knockdown approaches that may serve as new therapeutic targets for cancer treatment. This evidence concerns the gene HPSE and cancer.